pros and cons of glp-1 Is a right for you? Since the widespread adoption GLP-1 receptor agonists like Ozempic, Wegovy Munjaro for the management of metabolic disease and weight loss, there's been a growing RACGP - Examining the pros

Finally, limit alcohol intake as much as possible for at least two days following your treatment, and always feel free to report any issues to our team

EXPIRY: 03/2028 -01/2029

Drug Name: Semaglutide Manufacturer: Novo Nordisk Type: GLP-1 agonist Brand Names: Ozempic = Type 2 Diabetes, weekly injection (approved December, 2017) Rebylsus = Type 2 Diabetes, daily pill (approved September, 2019) Wegovy = Weight Loss, weekly injection (approved June, 2021) Drug Name: Tirzepatide Manufacturer: Eli Lilly Type: GLP-1/GIP co-agonist Brand Names: Mounjaro = Type 2 Diabetes, weekly injection (approved May, 2022) Zepbound = Weight Loss Application, weekly injection (approved November, 2023) (No pill form exists as of this writing) The short story is that both drugs were originally introduced as effective Type 2 Diabetes medications

2015;10: e0120440